共 8 条
[1]
Larranaga-Azcarate C., Campo-Molina G., Perez-Rodriguez A.F., Et al., Dinoprostone vaginal slow release system compared to expectant management in the active treatment of premature rupture of the membranes at term: Impact on maternal and fetal outcome, Acta obstetrica., 87, pp. 195-200, (2008)
[2]
Duff P., Premature rupture of membranes in term patients: Induction of labor versus expectant management, Clin Obstet Gynecol., 41, pp. 883-91, (1998)
[3]
Ozden S., Delikara M.N., Avci A., Et al., Intravaginal misoprostol vs expectant management in premature rupture of membranes with low bishop scores at term, Int J gynaecol obstet., 77, pp. 109-15, (2002)
[4]
Hoffmann R.A., Anthony J., Fawcus S., Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term, Int J of gynec obstet., 72, pp. 215-21, (2001)
[5]
Ayaz A., Saeed S., Farooq M.U., Et al., Pre-labor rupture of membranes at term in patients with an unfavorable cervix: Active versus conservative management, Taiwan J obstet gynecol., 47, pp. 192-6, (2008)
[6]
Da Graca Krupa F., Cecatti J.G., De Castro Surita F.G., Et al., Misoprostol versus expectant management in premature rupture of membranes at term, BJOG, 112, pp. 1284-90, (2005)
[7]
Akyol D., Mungan T., Unsal A., Et al., Prelabour rupture of membranes at term: No advantage of delaying induction for 24 hours, Aust N Z J Obstet Gynecol., 39, pp. 291-5, (1999)
[8]
Dare M.R., Middleton P., Crowther C.A., Et al., Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more), Cochrane Database Syst Rev., 1, (2006)